{"version":"1.0","type":"link","title":"Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer.","author_name":"Hu SW 외","author_url":"https://prs-insight.online/author/Hu%20SW","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/170481","thumbnail_width":1200,"thumbnail_height":630}